At the 2022 Interim Meeting of the American Medical Association (AMA), CEO James Madara, MD, talks about the focused approach driving innova

In this webinar hosted by SCRS in partnership with Teckro, hear from industry leaders, Chris Komelasky, Silvina Baudino, and Luckie Alexande

Trials that have a more heterogeneous study population are more generalisable to clinical practice and potentially have more external validi